1
... T I O N NFPA CODES Health 3 Fire 1 Reactivity 0 Specific Hazard Corrosive REVISION SUMMARY Rev. M ... 29 CFR 1910.1200 for guidance in the use of this information. 1.PRODUCT AND COMPANY IDENTIFICATION 2 ... T I O N NFPA CODES Health 3 Fire 1 Reactivity 0 Specific Hazard Corrosive REVISION SUMMARY Rev. M ... 29 CFR 1910.1200 for guidance in the use of this information. 1.PRODUCT AND COMPANY IDENTIFICATION 2 ... 1 ...
1
... ). Preliminary Program Note: *indicates keynote speaker. T h u rs d a y , 1 4 th N o v e m b e r, 2 0 1 9 Session ... Rillig 17.15-18.30 Poster Session and apero 19.00 Symposium dinner F ri d a y , 1 5 th N o v e m b e r, 2 ... ). Preliminary Program Note: *indicates keynote speaker. T h u rs d a y , 1 4 th N o v e m b e r, 2 0 1 9 Session ... Rillig 17.15-18.30 Poster Session and apero 19.00 Symposium dinner F ri d a y , 1 5 th N o v e m b e r, 2 ... 1 ...
Slide 1
... . Correspondence: sabine.rohrmann@uzh.ch 0 0.5 1 1.5 2 2.5 3 3.5 4 0.5 1 2 3 5 10+ Figure 1. Newly detected tumors ... Slide 1 Changes in autopsy rates among cancer patients and its impact from the public health point ... . Correspondence: sabine.rohrmann@uzh.ch 0 0.5 1 1.5 2 2.5 3 3.5 4 0.5 1 2 3 5 10+ Figure 1. Newly detected tumors ... Slide 1 ... Slide 1 ...
Folie 1
... (or death rate relative to general population) in obese patients was 2- 3 times higher compared with ... , Coory and Martin ( 2010). Breast Cancer Res Treat 123, 627ff. 2. Parekh, Chandran and Bandera (2012 ... (or death rate relative to general population) in obese patients was 2- 3 times higher compared with ... , Coory and Martin ( 2010). Breast Cancer Res Treat 123, 627ff. 2. Parekh, Chandran and Bandera (2012 ... Folie 1 ...
Slide 1
... cryostat Pulse tube cooled cryostat 3 8 c m 5 cm 7mm T . F re y, E T H P h D th e s is ( 2 0 1 3 ) Single ... . F re y e t a l, P R L 1 0 8 , 0 4 6 8 0 7 ( 2 0 1 2 ) p a rt s o f s lid e c o u rt e s y o f T h o ... cryostat Pulse tube cooled cryostat 3 8 c m 5 cm 7mm T . F re y, E T H P h D th e s is ( 2 0 1 3 ) Single ... . F re y e t a l, P R L 1 0 8 , 0 4 6 8 0 7 ( 2 0 1 2 ) p a rt s o f s lid e c o u rt e s y o f T h o ... Slide 1 ...
Dia 1
... metals leaching Data from other ESRs Part 2 (LCA of emerging processes) Part 1 (This poster) Part 3 ... mineralogy (ESRs) - Leaching tests (ESR 14) - Hydrology Data collection for LCA WP 2 and WP 3 Beneficiation ... metals leaching Data from other ESRs Part 2 (LCA of emerging processes) Part 1 (This poster) Part 3 ... mineralogy (ESRs) - Leaching tests (ESR 14) - Hydrology Data collection for LCA WP 2 and WP 3 Beneficiation ... Dia 1 ...
Folie 1
... patients • 2 cycles bortezomib (bi-weekly) and dexa every 21 days • And -6, - 3, + 1, +4 during HDM • 5 pts ... published (Majolino, BMT 1993) 2. First series showing organ improvement (Comenzo, Blood, 1998) 3 ... patients • 2 cycles bortezomib (bi-weekly) and dexa every 21 days • And -6, - 3, + 1, +4 during HDM • 5 pts ... published (Majolino, BMT 1993) 2. First series showing organ improvement (Comenzo, Blood, 1998) 3 ... Folie 1 ...
Slide 1
... region Regions identified: 2. Thermally valid – suboptimal designs 3. Exceedingly high HF losses 4 ... laws 𝑃𝑃coil,HF ∝ 𝑅𝑅𝑑𝑑𝑑𝑑𝐺𝐺𝑅𝑅𝐻𝐻𝑝𝑝𝑝𝑝,𝐻𝐻𝐻𝐻2 ∝ 𝑓𝑓2 ∝ 𝑓𝑓− 2 ∝ 1 With 𝑓𝑓 ↑ ⇒�𝑁𝑁 ... region Regions identified: 2. Thermally valid – suboptimal designs 3. Exceedingly high HF losses 4 ... laws 𝑃𝑃coil,HF ∝ 𝑅𝑅𝑑𝑑𝑑𝑑𝐺𝐺𝑅𝑅𝐻𝐻𝑝𝑝𝑝𝑝,𝐻𝐻𝐻𝐻2 ∝ 𝑓𝑓2 ∝ 𝑓𝑓− 2 ∝ 1 With 𝑓𝑓 ↑ ⇒𝑁𝑁 ... Slide 1 ...
Folie 1
... 0 1 2 3 4 Years after AVR 0.8 1 0.6 0.4 0.2 Su rv iv al (% ) 0 Type of LV hypertrophic remodeling ... (pumping dysfunction - HFrEF 0,0 2,0 4,0 6,0 8,0 10,0 12,0 14,0 < 1 0 10 - 1 4 15 - 1 9 20 - 2 4 25 - 2 9 30 - 3 ... 0 1 2 3 4 Years after AVR 0.8 1 0.6 0.4 0.2 Su rv iv al (% ) 0 Type of LV hypertrophic remodeling ... (pumping dysfunction - HFrEF 0,0 2,0 4,0 6,0 8,0 10,0 12,0 14,0 < 1 0 10 - 1 4 15 - 1 9 20 - 2 4 25 - 2 9 30 - 3 ... Folie 1 ...
Slide 1
... Karin Boettcher1 1 PerkinElmer Inc., 2 InSphero AG 3D microtissue formation and high content analysis 2 ... microtissues 3 Figure 2. Inhibition of growth of 3D tumor microtissues after 72 hrs of incubation with 5-FU or ... Karin Boettcher1 1 PerkinElmer Inc., 2 InSphero AG 3D microtissue formation and high content analysis 2 ... microtissues 3 Figure 2. Inhibition of growth of 3D tumor microtissues after 72 hrs of incubation with 5-FU or ... Slide 1 ...
